0 of 7 questions completed
Questions:
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
0 of 7 questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
You must score 0% to continue. Please click the link below to re-take the quiz
1. How confident are you in the management of patients with multiple sclerosis (MS) in your practice?
2. Initiation of a high-efficacy DMT within 2 years after diagnosis rather than later in the disease course decreases the risk for disability in patients with MS by what percentage?
3. According to current clinical trial evidence and meta analyses, which of the following DMT classes has the highest efficacy?
4. Which of the following would you prescribe for a patient newly diagnosed with RRMS who, based on her prognosis and preferences, is a reasonable candidate for a moderate-efficacy DMT?
5. Which of the following DMTs is the best option for a patient at high risk for rapid MS progression, and a preference for therapies with minimal monitoring requirements?
6. What is the mechanism by which BTK inhibitors block demyelination in the setting of MS?
7. Which of the following is a risk factor for more severe COVID-19 in patients with MS?